Apollo Hospitals EnterpriseNSE: APOLLOHOSPBSE: 508869Healthcare · Hospital

₹8,957.0031.00 (0.34%)

Mkt Cap: ₹1.29 L Cr.
P/E (TTM): 66.29
Open: ₹9,025.00
Day's Range: ₹8,931.00 – ₹9,036.50
52W Range: ₹6,696.50 – ₹9,009.00
Div Yield: 0.22%
EPS (TTM): ₹134.92
Book Value: ₹659.47

Apollo Hospitals Enterprise Financial Statements

Name: Apollo Hospitals Enterprise Financials — historical data
Creator: StockeZee

For Mar 2026, Apollo Hospitals Enterprise reported revenue of ₹25,229 crore and net profit of ₹1,942 crore. Return on equity stands at 22.10%. Profit & loss, balance sheet and cash flow across 9 reported years are below.

Updated 31 Jul 2026Source: NSE & BSE company filingsNifty 50 constituent

Latest year revenue: ₹25,229 Cr
EBITDA: ₹3,769 Cr
Operating margin: 14.94%
Profit after tax: ₹1,942 Cr
Net margin: 7.7%
EPS: ₹135.04
Latest year: Mar 2026
Years reported: 9

Apollo Hospitals Enterprise profit & loss

Reported annual performance for Apollo Hospitals Enterprise, oldest to newest. Figures in ₹ crore unless a row states otherwise.

Apollo Hospitals Enterprise annual profit and loss statement. Figures in ₹ crore unless a row states otherwise.
Line item	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue from Operations	8,243	9,617	11,247	10,560	14,663	16,612	19,059	21,794	25,229
Sales Growth YoY %	—	16.67%	16.94%	-6.11%	38.85%	13.3%	14.73%	14.35%	15.76%
Other Income	32	31	27	45	78	90	106	200	192
Total Income	8,276	9,649	11,274	10,605	14,741	16,703	19,166	21,994	25,420
Cost of Goods Sold (COGS)	4,033	4,661	5,499	5,684	7,573	8,574	9,806	11,310	13,076
Cost of Materials Consumed	1,461	1,645	1,809	1,623	2,685	2,284	2,454	2,754	3,041
Purchases of Stock-in-Trade	2,650	3,088	3,797	4,186	4,961	6,315	7,385	8,557	10,056
Changes in Inventories	-78	-72	-107	-125	-73	-25	-34	-1	-22
Gross Profit	4,211	4,957	5,748	4,876	7,089	8,038	9,254	10,484	12,153
Gross Margin %	51.08%	51.54%	51.11%	46.17%	48.35%	48.39%	48.55%	48.1%	48.17%
Total Operating Expenses	3,418	3,893	4,161	3,738	4,904	5,989	6,863	7,462	8,384
Employee Benefit Expense	1,404	1,598	1,853	1,601	1,787	2,144	2,494	2,769	3,000
Other Expenses	2,013	2,295	2,308	2,137	3,118	3,845	4,369	4,693	5,383
EBITDA	793	1,064	1,587	1,137	2,185	2,050	2,391	3,022	3,769
OPM %	9.62%	11.06%	14.11%	10.77%	14.9%	12.34%	12.54%	13.87%	14.94%
Total Non-Operating Expenses	654	723	1,351	1,083	1,273	996	1,138	1,216	1,307
Depreciation & Amortisation	359	396	620	573	601	615	687	758	876
Finance Costs	295	327	533	449	379	381	449	459	450
Exceptional Items (Before Tax)	0	0	198	61	294	0	2	0	-19
Profit Before Tax (PBT)	171	373	660	221	1,578	1,144	1,363	2,006	2,616
Tax Expense	112	173	225	85	477	256	446	534	658
Current Tax	88	126	214	76	238	406	437	526	629
Deferred Tax	24	47	11	9	239	-150	9	8	29
Effective Tax %	65.35%	46.53%	34.11%	38.38%	30.23%	22.4%	32.7%	26.62%	25.16%
Total Profit for Period	60	200	432	137	1,108	845	935	1,505	2,003
Less: Non-controlling Interests	-58	-36	-23	-14	53	26	36	59	61
Net Profit (Owner's PAT)	117	236	455	150	1,056	819	899	1,446	1,942
Net Profit Margin %	1.42%	2.45%	4.05%	1.42%	7.2%	4.93%	4.71%	6.63%	7.7%
PAT Growth YoY %	—	101.03%	92.73%	-66.95%	602.01%	-22.41%	9.71%	60.91%	34.29%
Earnings Per Share (EPS)	₹8.44	₹16.97	₹32.7	₹10.46	₹73.42	₹56.97	₹62.5	₹100.56	₹135.04
Diluted Shares Outstanding (Cr.)	14	14	14	14	14	14	14	14	14
Profit/Loss from Associates	0	1	-3	1	7	-43	18	33	45
Other Comprehensive Income (Net of Tax)	-17	-29	-1	15	-10	-13	-10	-6	58
Expenses	8,104	9,276	10,614	10,384	13,163	15,559	17,803	19,988	22,804
Material Cost %	17.72%	17.1%	16.09%	15.37%	18.32%	13.75%	12.88%	12.64%	12.05%
Employee Cost %	17.04%	16.62%	16.48%	15.16%	12.18%	12.9%	13.08%	12.71%	11.89%
Other Cost %	24.42%	23.86%	20.52%	20.24%	21.26%	23.14%	22.92%	21.53%	21.34%
Interest Coverage (x)	1.47	2.04	1.82	1.26	4.18	3.77	3.79	4.94	6.44

Apollo Hospitals Enterprise revenue and profit trend

Reported annual revenue and net profit, oldest to newest. Two panels because the two measures live on different scales — one shared axis would distort both.

Apollo Hospitals Enterprise balance sheet

Assets, liabilities and shareholders' equity as reported, in Schedule III order. Figures in ₹ crore unless a row states otherwise.

Apollo Hospitals Enterprise annual balance sheet with assets, liabilities and equity. Figures in ₹ crore unless a row states otherwise.
Line item	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Total Equity	3,469	3,470	4,803	5,899	6,531	7,321	8,653	9,975
Equity Share Capital	70	70	72	72	72	72	72	72
Reserves & Surplus	3,264	3,270	4,531	5,573	6,125	6,864	8,140	9,408
Equity Method Investments	365	324	313	205	186	198	224	256
Total Equity	3,469	3,470	4,803	5,899	6,531	7,321	8,653	9,975
Non-Current Liabilities	3,759	5,828	4,577	4,932	4,572	4,768	7,426	5,741
Long-term Borrowings	2,952	3,021	2,473	2,427	1,938	2,236	4,417	2,430
Deferred Tax Liabilities	315	294	260	530	442	450	458	498
Non-Current Provisions	11	10	22	23	57	73	89	100
Other Non-Current Liabilities	3	0	0	19	20	18	17	13
Non-Current Financial Liabilities	3,430	5,523	4,294	4,359	4,052	4,227	6,862	5,130
Current Liabilities	1,955	2,041	2,038	2,383	3,325	4,665	4,579	6,481
Short-term Borrowings	498	258	21	208	773	926	858	3,228
Trade Payables	713	909	1,160	1,632	1,916	2,369	2,241	2,252
Current Financial Liabilities	1,707	1,729	1,801	2,118	2,972	4,283	4,134	5,975
Other Current Financial Liabilities	496	562	620	277	283	988	1,035	495
Other Current Liabilities	145	189	127	144	238	237	264	308
Current Provisions	102	123	109	119	113	143	179	195
Current Tax Liabilities	1	0	1	3	3	1	2	3
Total Liabilities	5,714	7,869	6,614	7,315	7,896	9,433	12,005	12,222
Total Non-Current Assets	6,902	8,692	7,775	9,093	10,091	11,473	13,629	15,297
Property, Plant & Equipment (PPE)	4,594	7,052	6,334	7,235	7,432	8,541	9,816	11,039
Capital Work-in-Progress	822	233	212	44	602	845	771	992
Intangible Assets	35	28	64	106	98	108	139	199
Investment Property	7	6	5	5	4	3	3	2
Non-Current Investments	28	35	32	96	96	104	830	906
Loans – Non-Current	11	23	18	8	8	7	27	16
Other Non-Current Assets	442	408	231	130	362	365	412	252
Non-Current Financial Assets	273	292	194	435	401	363	1,070	1,471
Net Fixed Assets	5,451	7,313	6,609	7,385	8,131	9,493	10,726	12,229
Total Current Assets	2,282	2,647	3,641	4,121	4,337	5,280	7,029	6,900
Inventories	585	738	249	432	390	460	481	542
Trade Receivables	1,023	1,027	1,331	1,768	2,234	2,515	3,016	3,485
Cash & Cash Equivalents	283	381	425	583	433	506	578	811
Current Investments	69	75	998	501	292	684	1,432	1,017
Loans – Current	8	7	5	4	6	5	5	2
Current Financial Assets	1,576	1,678	3,220	3,497	3,602	4,304	5,996	6,357
Other Current Assets	121	231	172	193	345	516	552	—
Other Current Financial Assets	129	102	162	188	294	166	182	737
Net Working Capital	326	606	1,604	1,738	1,012	615	2,450	419
Additional Asset Fields	153	131	225	263	346	396	454	509
Def Tax Assets	17	—	25	8	12	11	13	14
Non Controlling Int	135	131	200	254	334	385	441	494
Total Assets	9,183	11,339	11,417	13,214	14,428	16,753	20,657	22,197
Total Borrowings	3,450	3,279	2,495	2,636	2,710	3,162	5,275	5,659
Net Debt	3,168	2,899	2,069	2,053	2,277	2,656	4,697	4,847
Debt to Equity (x)	0.99	0.95	0.52	0.45	0.41	0.43	0.61	0.57
Current Ratio (x)	1.17	1.3	1.79	1.73	1.3	1.13	1.54	1.06

Apollo Hospitals Enterprise cash flow statement

Cash generated and used across operating, investing and financing activities. Figures in ₹ crore unless a row states otherwise.

Apollo Hospitals Enterprise annual cash flow statement across operating, investing and financing activities. Figures in ₹ crore unless a row states otherwise.
Line item	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Net Cash from Operating Activities	1,616	1,377	1,920	2,136	2,856
Profit Before Tax	1,578	1,144	1,363	2,006	2,616
Depreciation & Amortisation	601	615	687	758	876
Finance Costs	379	381	449	459	450
Working Capital Changes	-392	-450	-193	-606	-574
Tax Paid	-204	-382	-467	-494	-606
Net Cash from Investing Activities	-791	-857	-1,537	-3,381	-2,148
Purchase of PPE	-657	-1,129	-1,137	-1,713	-1,962
Sale of Fixed Assets	5	4	-1,169	15	31
Interest Received	36	44	39	84	84
Net Cash from Financing Activities	-768	-633	-311	1,317	-478
Proceeds from Borrowings	426	585	707	2,551	1,115
Repayment of Borrowings	-712	-516	-254	-442	-734
Interest Paid	-376	-251	-303	-302	-278
Dividend Paid	-43	-258	-221	-278	-293
Buyback / Redemption of Shares	0	0	0	0	0
Lease Liabilities Paid	-60	-197	0	-256	-291
Net Change in Cash	57	-113	72	73	230
Effect of Foreign Exchange Changes	0	0	0	0	0
Free Cash Flow	958	249	784	424	894
CFO / PBT (x)	1.02	1.2	1.41	1.06	1.09

Apollo Hospitals Enterprise key ratios

Valuation, profitability, return, leverage and per-share measures computed from reported statements — not from adjusted or normalised earnings.

Apollo Hospitals Enterprise trades at a P/E of 66.29× against a sector median of 47.11× — a 41% premium. Sector comparisons can mislead for conglomerates with mixed business lines.

Apollo Hospitals Enterprise valuation, profitability, return and leverage ratios
Ratio	Category	Value
P/E (TTM)	Valuation	66.29
Forward P/E	Valuation	39.93
P/B	Valuation	13.58
PEG (TTM)	Valuation	1.91
EV / EBITDA (TTM)	Valuation	33.61
P/S (TTM)	Valuation	5.12
Operating margin	Profitability	14.9%
Net margin (TTM)	Profitability	7.56%
Return on equity	Return ratios	22.1%
Return on capital employed	Return ratios	17.9%
Return on assets	Return ratios	8.44%
Debt to equity	Leverage & liquidity	0.9
Beta	Leverage & liquidity	0.58
EPS (TTM)	Per share	₹134.92
Book value	Per share	₹659.47
Revenue / share (TTM)	Per share	₹1,705.13
Cash flow / share	Per share	₹198.61
Dividend yield	Shareholder returns	0.22%
Dividend payout (TTM)	Shareholder returns	14.84%

How this is calculated

Statements are as filed with the exchanges. Consolidated figures are shown where reported. Figures are in rupees crore unless the table states otherwise. Ratios are computed from the same reported statements, not from adjusted or normalised earnings.

Index membership reflects the Nifty 100 as published by NSE Indices, effective 2026-03-30.

Apollo Hospitals Enterprise: frequently asked questions

What is Apollo Hospitals Enterprise's annual revenue?

Apollo Hospitals Enterprise reported revenue of ₹25,229 crore in Mar 2026, up 15.8% on the previous financial year.

Is Apollo Hospitals Enterprise profitable?

Apollo Hospitals Enterprise reported a net profit of ₹1,942 crore in Mar 2026, up 34.3% on the previous financial year.

What is Apollo Hospitals Enterprise's EPS?

Apollo Hospitals Enterprise reported earnings per share of ₹135.04 for Mar 2026.

What is Apollo Hospitals Enterprise's operating margin?

Apollo Hospitals Enterprise's operating margin for Mar 2026 was 14.94%.

What is Apollo Hospitals Enterprise's return on equity?

Apollo Hospitals Enterprise's return on equity stands at 22.10%. ROE measures profit generated per rupee of shareholder equity.

How many years of Apollo Hospitals Enterprise financials are shown?

9 reported financial years are tabulated on this page, the most recent being Mar 2026.

Are these figures consolidated or standalone?

Consolidated figures are shown wherever the company reports them, and standalone otherwise. The basis in use is labelled on the statement table.

More Apollo Hospitals Enterprise data

Compare financial statements with peers

Explore

Comparing financial statements across companies is more useful than reading one in isolation — the peer links above open the same view for Apollo Hospitals Enterprise’s closest listed competitors.

Disclaimer

The data, ratios and commentary about Apollo Hospitals Enterprise Ltd (APOLLOHOSP) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.